Announced
Completed
Financials
Tags
Cross Border
Biotechnology
Private Equity
Friendly
Venture Capital
Minority
Completed
digital health
Single Bidder
Private
United Kingdom
Acquisition
Synopsis
Tencent and Legal & General led a $50m Series C funding round in Congenica, a digital health company. Additional investors include Xeraya, Puhua Capital, IDO Investments, Parkwalk, Cambridge Innovation Capital and Downing. "Genomic medicine is revolutionising healthcare, transforming outcomes for patients by providing clinicians with fast, accurate and early diagnoses and the information needed to provide life-changing answers for their patients, improving wellbeing and disease management. This new funding will allow us to build on our established foundation in rare disease and bring the power of our platform to new indications and new markets. We welcome our new investors to Congenica and are grateful to our existing investors for their continued support," David Atkins, Congenica CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.